Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.

Some studies have shown that sorafenib could significantly prolong the overall survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization (TACE). However, other studies revealed that patients had no access to sorafenib-related survival benef...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 30; no. 1; pp. 476 - 492
Autores principales:	He, Kun, Yang, Zelong, Liu, Xinyu, Yang, Yanling, Song, Wenjie, Wang, Shangyu, Chen, Yong
Formato:	Journal Article
Publicado:	MDPI Jan2023
Acceso en línea:	Ver este registro en EBSCOhost